☰

Jonathan C. Cheng, Ph.D. - Publications

Affiliations: 
2003 University of Southern California, Los Angeles, CA, United States 
Area:
DNA methylation, cancer, epigenetics
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cheng JC, Chiang MT, Lee CH, Liu SY, Chiu KC, Chou YT, Huang RY, Huang SM, Shieh YS. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Journal of Dental Research. PMID 26661712 DOI: 10.1177/0022034515621728  0.448
2015 Gupta S, O'Donnell P, Plimack ER, Berger R, Montgomery B, Heath K, Dolled-Filhart M, Pathiraja K, Gause CK, Cheng J, Perini R, Bellmunt J. MP68-11 A PHASE 1B STUDY OF PEMBROLIZUMAB (PEMBRO; MK-3475) FOR ADVANCED UROTHELIAL CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2473  0.346
2014 Lai ZL, Tsou YA, Fan SR, Tsai MH, Chen HL, Chang NW, Cheng JC, Chen CM. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma. Biomed Research International. 2014: 378358. PMID 25197641 DOI: 10.1155/2014/378358  0.464
2005 Marquez VE, Kelley JA, Agbaria R, Ben-Kasus T, Cheng JC, Yoo CB, Jones PA. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Annals of the New York Academy of Sciences. 1058: 246-54. PMID 16394141 DOI: 10.1196/Annals.1359.037  0.733
2005 Marquez VE, Barchi JJ, Kelley JA, Rao KV, Agbaria R, Ben-Kasus T, Cheng JC, Yoo CB, Jones PA. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology. Nucleosides, Nucleotides & Nucleic Acids. 24: 305-18. PMID 16247946 DOI: 10.1081/Ncn-200059765  0.729
2005 Friedrich MG, Chandrasoma S, Siegmund KD, Weisenberger DJ, Cheng JC, Toma MI, Huland H, Jones PA, Liang G. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. European Journal of Cancer (Oxford, England : 1990). 41: 2769-78. PMID 16242928 DOI: 10.1016/J.Ejca.2005.07.019  0.625
2004 Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7457-65. PMID 15569975 DOI: 10.1158/1078-0432.Ccr-04-0930  0.77
2004 Yoo CB, Cheng JC, Jones PA. Zebularine: a new drug for epigenetic therapy. Biochemical Society Transactions. 32: 910-2. PMID 15506921 DOI: 10.1042/Bst0320910  0.759
2004 Cheng JC, Yoo CB, Weisenberger DJ, Chuang J, Wozniak C, Liang G, Marquez VE, Greer S, Orntoft TF, Thykjaer T, Jones PA. Preferential response of cancer cells to zebularine. Cancer Cell. 6: 151-8. PMID 15324698 DOI: 10.1016/J.Ccr.2004.06.023  0.769
2004 Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT, Weisenberger DJ, Egger G, Takai D, Gonzales FA, Jones PA. Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. Proceedings of the National Academy of Sciences of the United States of America. 101: 7357-62. PMID 15123803 DOI: 10.1073/Pnas.0401866101  0.732
2004 Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, Jones PA. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Molecular Cancer Research : McR. 2: 62-72. PMID 14757847  0.573
2004 Cheng JC, Weisenberger DJ, Gonzales FA, Liang G, Xu GL, Hu YG, Marquez VE, Jones PA. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Molecular and Cellular Biology. 24: 1270-8. PMID 14729971 DOI: 10.1128/Mcb.24.3.1270-1278.2004  0.651
2004 Friedrich M, Liang G, Siegmund K, Weisenberger D, Cheng J, Toma M, Jones P, Huland H. 212 Frequent methylation of apoptosis-associated genes in bladder cancer cell lines, tumour samples, and urine samples for diagnosis of bladder cancer European Urology Supplements. 3: 55. DOI: 10.1016/S1569-9056(04)90213-8  0.552
2004 Friedrich MG, Liang G, Weisenberger DJ, Cheng JC, Siegmund KD, Toma MI, Huland H, Jones PA. 745: Frequent Methylation of Apoptosis-Associated Genes in Bladder Cancer Cell Lines, Tumor Samples, and Urine Samples for Diagnosis of Bladder Cancer Journal of Urology. 171: 198-198. DOI: 10.1016/s0022-5347(18)37994-1  0.431
2004 Friedrich MG, Liang G, Toma MI, Weisenberger DJ, Cheng JC, Siegmund KD, Huland H, Jones PA. 743: Methylation of the E-Cadherin and the TIMP-3 Genes are Positive Prognostic Markers for Patients with Non-Muscle Invasive Bladder Carcinoma Journal of Urology. 171: 197-197. DOI: 10.1016/S0022-5347(18)37992-8  0.504
2003 Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, Selker EU. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. Journal of the National Cancer Institute. 95: 399-409. PMID 12618505 DOI: 10.1093/Jnci/95.5.399  0.628
2001 Markl ID, Cheng J, Liang G, Shibata D, Laird PW, Jones PA. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Research. 61: 5875-84. PMID 11479229  0.715
Show low-probability matches.